Compare MP Materials (MP) vs Sanofi SA (SNY) Price & Performance

MP MaterialsTrade

Sanofi SATrade

Price performance (Past 24H)

Key statistics

MP Materials vs Sanofi SA — how do they compare? MP Materials trades at $46.86 (market cap $8.25B), while Sanofi SA trades at $40.1 (market cap $96.81B). The key difference: Sanofi SA is far larger — about 11.7× MP Materials's market cap, and Sanofi SA pays a 6.02% dividend while MP Materials pays none. Which is the better fit depends on your goals — on Pluang, investors hold MP Materials for 11 Days and Sanofi SA for 94 Days on average.

	MP	SNY
Market Cap	$8.25B	$96.81B
Volume	5,934,023	2,081,815
Sector	Basic Materials	Health
52-Week High	$98.65	$52.34
52-Week Low	$38.10	$39.51
Typical Hold Time	11 Days	94 Days
Enterprise Value	$7.73B	$116.20B
Dividend Yield	—	6.02%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MP Materials

No Aura AI signal available yet.

Sanofi SA

SNY trades at $40.2, up 1.62% on the day, with a bearish technical signal from moving averages but a neutral oscillator stance. The company reported revenue of $46.72B in 2025 with a net income margin of 16.72%, and it has beaten EPS estimates for the last three quarters. Recent news highlights a significant $8B immunology alliance expansion with Regeneron, signaling strong pipeline development.

The outlook is mixed; analyst consensus leans hold (51.86%) with a buy rating at 44.44%, reflecting optimism on new drug launches but caution over future profit margin compression projected for 2026. Key risks include execution of the expanded Regeneron partnership and managing debt levels amid investing cash flow volatility.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

81% Buy19% Sell

Avg holding period · 11 Days

SNY

No sentiment data available yet.

Top news

Latest headlines on both assets

Critical metals stocks fall again; builders like USA Rare Earth drop sharply, producers like MP Materials hold better.24/7 Wall Street · 20 hours agoBearish Rare earth stocks drop 3-5% amid sector-wide selloff without company-specific news.24/7 Wall Street · 1 day agoBearish Pentagon invests $400M in MP Materials to break China's rare earth magnet monopoly, GM first to receive non-China magnets.24/7 Wall Street · 4 days agoBullish View details →

SNY

Biopharma leaders showcase AI and cloud tech to speed drug development at Veeva SummitPRNewsWire · 1 day agoBullish Novavax jumps 22% as Sanofi advances Nuvaxovid for fall vaccinations, outpacing Moderna and BioNTech.24/7 Wall Street · 3 days agoBullish View details →

About MP Materials

MP Materials mines, refines, and manufactures rare earth materials and magnets in the United States. Its products are used in transportation, energy, robotics, defense, and aerospace applications.

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.